Download Synthesis and Characterization of Heterocyclic Derivatives as Potent and Selective Adenosine Receptors' Antagonists.

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Discovery and development of cyclooxygenase 2 inhibitors wikipedia , lookup

Drug design wikipedia , lookup

Toxicodynamics wikipedia , lookup

NMDA receptor wikipedia , lookup

Drug discovery wikipedia , lookup

CCR5 receptor antagonist wikipedia , lookup

5-HT2C receptor agonist wikipedia , lookup

Psychopharmacology wikipedia , lookup

Discovery and development of antiandrogens wikipedia , lookup

5-HT3 antagonist wikipedia , lookup

Discovery and development of angiotensin receptor blockers wikipedia , lookup

Nicotinic agonist wikipedia , lookup

Discovery and development of ACE inhibitors wikipedia , lookup

Neuropharmacology wikipedia , lookup

NK1 receptor antagonist wikipedia , lookup

Cannabinoid receptor antagonist wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Transcript
NUS Graduate School for Integrative Sciences and Engineering
Research Project Write-up
PROJECT 2
Title of Project :
SYNTHESIS AND CHARACTERIZATION OF
HETEROCYCLIC DERIVATIVES AS POTENT AND
SELECTIVE
ADENOSINE
RECEPTORS’
ANTAGONISTS
Name of Supervisor :
Giorgia Pastorin
Contact Details:
Tel: 6516 1876; email: [email protected]
Short Description
Adenosine’s receptors (A1, A2A, A2B and A3) represent promising drug targets, since
the modulation of adenosine activity, especially if very selective, might be beneficial
in certain disorders (for example cancer and inflammation (A3), asthma, type-II
diabetes, Alzheimer’s disease and cystic fibrosis (A2B)).
In particular, we are investigating some heterocyclic systems, whose basic structure
has resulted to be a potent inhibitor of these receptors, with different degrees of
affinity and selectivity. Although many details concerning these structures are now
available, a selective and potent antagonist especially towards A3 and A2B receptor
subtypes is still highly defective.
Therefore, this project is intended to obtain a certain library of compounds in order to
better understand the critical parameters that are involved in the ligand-receptor
interaction.